Harvard Bioscience Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Harvard Bioscience Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- HBIO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001123494
Board of directors
-
Alan I. Edrick · DirectorSince 2023
-
Bertrand Loy · DirectorSince 2023
-
James W. Green · Director · Chief Executive OfficerSince 2023
-
Jennifer Cote · Director · Chief Financial OfficerSince 2024
-
Katherine A. Eade · DirectorSince 2023
-
Thomas W. Loewald · DirectorSince 2023
Chief executives
James W. Green
· Chief Executive Officer
Dates unknown
Board connections
1 of this board's directors also sit on 1 other board.
- via Bertrand Loy
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 13, 2024 | James W. Green Director, Officer (Chief Executive Officer) | Open-market purchase | +10,000 | $2.91 | $29,100 |
| Jun 6, 2024 | James W. Green Director, Officer (Chief Executive Officer) | Open-market purchase | +20,000 | $3.07 | $61,400 |
| May 21, 2024 | Bertrand Loy Director | Grant or award | +56,575 | — | — |
| May 21, 2024 | Thomas W. Loewald Director | Grant or award | +45,872 | — | — |
| May 21, 2024 | Katherine A. Eade Director | Grant or award | +45,872 | — | — |
| May 21, 2024 | Alan I. Edrick Director | Grant or award | +45,872 | — | — |
| Mar 6, 2024 | Jennifer Cote Officer (Chief Financial Officer) | Shares withheld for tax | −9,920 | $4.11 | $40,771 |
| Mar 5, 2024 | Jennifer Cote Officer (Chief Financial Officer) | Grant or award | +35,800 | — | — |
| Mar 5, 2024 | James W. Green Director, Officer (Chief Executive Officer) | Grant or award | +214,797 | — | — |
| Mar 5, 2024 | Jennifer Cote Officer (Chief Financial Officer) | Grant or award | +35,800 | — | — |
| Mar 5, 2024 | James W. Green Director, Officer (Chief Executive Officer) | Grant or award | +214,797 | — | — |
| Dec 31, 2023 | James W. Green Director, Officer (Chief Executive Officer) | Shares withheld for tax | −82,790 | $5.35 | $442,927 |
| Dec 29, 2023 | James W. Green Director, Officer (Chief Executive Officer) | Shares withheld for tax | −24,187 | $5.35 | $129,400 |
| Dec 29, 2023 | Jennifer Cote Director, Officer (Chief Financial Officer) | Shares withheld for tax | −3,279 | $5.35 | $17,543 |
| Dec 29, 2023 | James W. Green Director, Officer (Chief Executive Officer) | Shares withheld for tax | −28,783 | $5.35 | $153,989 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.